Alnylam Pharmaceuticals Inc. (ALNY) Social Stream
ALNYLAM PHARMACEUTICALS INC (ALNY) Price Targets From Analysts
Use the tables below to see what analysts covering ALNYLAM PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-19 | 17 | $275 | $108 | $200 | $220.25 | -9.19% |
| 2021-11-22 | 18 | $275 | $108 | $200 | $220.25 | -9.19% |
| 2021-12-29 | 19 | $275 | $108 | $202.5 | $220.25 | -8.06% |
| 2022-01-11 | 19 | $275 | $108 | $203.85 | $220.25 | -7.45% |
| 2022-01-18 | 19 | $275 | $108 | $203.3 | $220.25 | -7.7% |
| 2022-01-23 | 19 | $350 | $108 | $208.3 | $220.25 | -5.43% |
| 2022-01-28 | 18 | $350 | $109 | $208.25 | $220.25 | -5.45% |
| 2022-02-10 | 18 | $350 | $109 | $208.65 | $220.25 | -5.27% |
| 2022-02-14 | 16 | $350 | $103 | $211.684 | $220.25 | -3.89% |
| 2022-02-22 | 15 | $350 | $103 | $214.166 | $220.25 | -2.76% |
| 2022-03-10 | 16 | $350 | $103 | $214.631 | $220.25 | -2.55% |
| 2022-04-04 | 15 | $350 | $103 | $211.277 | $220.25 | -4.07% |
| 2022-04-12 | 15 | $400 | $103 | $214.055 | $220.25 | -2.81% |
| 2022-04-19 | 15 | $400 | $103 | $214.277 | $220.25 | -2.71% |
| 2022-04-25 | 15 | $400 | $103 | $214.277 | $220.25 | -2.71% |
| 2022-04-28 | 15 | $400 | $103 | $212.5 | $220.25 | -3.52% |
| 2022-05-02 | 14 | $400 | $96 | $210.944 | $220.25 | -4.23% |
| 2022-06-06 | 15 | $430 | $96 | $211.888 | $220.25 | -3.8% |
| 2022-06-15 | 16 | $430 | $96 | $211.888 | $220.25 | -3.8% |
| 2022-06-22 | 16 | $430 | $98 | $212.333 | $220.25 | -3.59% |
| 2022-07-22 | 18 | $430 | $97 | $210.157 | $220.25 | -4.58% |
| 2022-07-29 | 18 | $430 | $97 | $209.631 | $220.25 | -4.82% |
| 2022-08-03 | 18 | $430 | $97 | $207.842 | $220.25 | -5.63% |
| 2022-08-04 | 19 | $430 | $155 | $230.277 | $220.25 | 4.55% |
| 2022-08-13 | 19 | $430 | $155 | $233.117 | $220.25 | 5.84% |
| 2022-08-22 | 19 | $430 | $155 | $231.5 | $220.25 | 5.11% |
| 2022-09-17 | 19 | $430 | $155 | $236.5 | $220.25 | 7.38% |
| 2022-10-02 | 19 | $430 | $155 | $237.888 | $220.25 | 8.01% |
| 2022-10-03 | 19 | $430 | $155 | $240.058 | $220.25 | 8.99% |
| 2022-10-07 | 18 | $430 | $155 | $240.058 | $220.25 | 8.99% |
| 2022-10-12 | 18 | $430 | $155 | $239.941 | $220.25 | 8.94% |
| 2022-10-21 | 18 | $430 | $155 | $239.882 | $220.25 | 8.91% |
| 2022-10-24 | 18 | $430 | $155 | $239.647 | $220.25 | 8.81% |
| 2022-10-28 | 18 | $430 | $142 | $238.352 | $220.25 | 8.22% |
| 2022-10-31 | 20 | $430 | $142 | $239.888 | $220.25 | 8.92% |
| 2022-11-02 | 20 | $415 | $142 | $238.894 | $220.25 | 8.46% |
| 2022-11-07 | 20 | $415 | $145 | $239.052 | $220.25 | 8.54% |
The Trend in the Analyst Price Target
Over the past 19 months, ALNY's average price target has gone up $64.05.
ALNY reports an average of 32.69% for its upside potential over the past 47 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-23 | 19 | 350 | 108 | 208.300 | 136.41 | 52.7% |
| 2022-04-12 | 15 | 400 | 103 | 214.055 | 159.58 | 34.14% |
| 2022-04-27 | 15 | 400 | 103 | 212.500 | 154.92 | 37.17% |
| 2022-06-09 | 16 | 430 | 96 | 211.888 | 135.00 | 56.95% |
| 2022-10-24 | 18 | 430 | 142 | 238.882 | 195.85 | 21.97% |
ALNY Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.7 | 12 | 2 | 6 | 0 | 0 | 20 |
The Trend in the Broker Recommendations
Over the past 31 months, ALNY's average broker recommendation rating worsened by 0.08.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of Pharmaceutical Products stocks, ALNYLAM PHARMACEUTICALS INC's number of analysts covering the stock is higher than 4299.08% of them.
- ALNYLAM PHARMACEUTICALS INC's average analyst price target is greater than 4262.21% of Pharmaceutical Products stocks.
- ALNY has a lower variance in analysts' estimates than -4037.99% of stocks in the large market cap category.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, ALNYLAM PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 384.96% of them.
In the Pharmaceutical Products industry, UTHR, NKTR, and IONS are the three stocks most similar to ALNYLAM PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding ALNY using the data that counts. Try POWR Ratings for free.